Media Summary: Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ... What were the key takeaways from this year's

Aasld Easl Special Conference Session 3 Therapeutic Options - Detailed Analysis & Overview

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ... What were the key takeaways from this year's Friday, February 23, 2024 1:45 PM - 4:00 PM PT Subject: Great Back to time and we are starting um scientific In this video, Prof. Norah Terrault, Prof. Thomas Berg and Prof. Raymond Chung discuss the highlights and new advances ...

In an insight-laden conversation recorded on site from Washington DC, Scott Friedman, Jörn Schattenberg, Rachel Zayas and ... This video was taken at The Liver Meeting 2013. The recipient of this award was Roger Williams, C.B.E. MD, FRCP, FRCS, ... In this episode of Better Edge, Sean W. P. Koppe, MD, moderates a panel of Northwestern Medicine hepatologists as they discuss ... Date: Saturday August 8, 2020 Moderators: Dr. Grace Wong (Hong Kong), Dr. Fu-Sheng Wang (Beijing) Topics & Speakers Topic ... Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ...

Photo Gallery

AASLD/EASL Special Conference Session 3: Therapeutic Options
AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians
Session 3  Best of EASL – 2025
AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV
Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines
EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology
Session 3 - Therapeutic Approaches | 2024 VCP International Scientific Conference
The International Liver Congress™ 2018 (ILC) - Press Conference 3
Scientific Session III with Distinguished Moderator (Papers 12-14)
Legends Speak Part 2 | APASL STC & BUILD 3.0 | Day 3 Hall A
Debrief of EASL Special Conference on New Perspectives in HCV Infection
S3-E53 - AASLD 2022 Liver Meeting Live Coverage: Part 1
Sponsored
Sponsored
View Detailed Profile
AASLD/EASL Special Conference Session 3: Therapeutic Options

AASLD/EASL Special Conference Session 3: Therapeutic Options

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral

AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians

AASLD/EASL HCV Special Conference Session 2: Viral Resistance Perspectives for Clinicians

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral

Sponsored
Session 3  Best of EASL – 2025

Session 3 Best of EASL – 2025

Day 2 Hall 1 INASL 2025.

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

AASLD/EASL HCV Special Conference Session 1: Birth Cohort Screening for HCV

Two major developments—the recommendation for birth cohort screening and the recent approval of all-oral

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Insights From 2025 EASL & AASLD Chronic Hepatitis B Guidelines

Dr. Anthony Martinez, Medical Director of Hepatology at the University at Buffalo and Erie County Medical Center, discusses the ...

Sponsored
EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

EASL Studio S9E10 - Decoding AASLD The Liver Meeting: Trends Shaping Hepatology

What were the key takeaways from this year's

Session 3 - Therapeutic Approaches | 2024 VCP International Scientific Conference

Session 3 - Therapeutic Approaches | 2024 VCP International Scientific Conference

Friday, February 23, 2024 1:45 PM - 4:00 PM PT Subject:

The International Liver Congress™ 2018 (ILC) - Press Conference 3

The International Liver Congress™ 2018 (ILC) - Press Conference 3

Third official press

Scientific Session III with Distinguished Moderator (Papers 12-14)

Scientific Session III with Distinguished Moderator (Papers 12-14)

Great Back to time and we are starting um scientific

Legends Speak Part 2 | APASL STC & BUILD 3.0 | Day 3 Hall A

Legends Speak Part 2 | APASL STC & BUILD 3.0 | Day 3 Hall A

Topics covered in this

Debrief of EASL Special Conference on New Perspectives in HCV Infection

Debrief of EASL Special Conference on New Perspectives in HCV Infection

In this video, Prof. Norah Terrault, Prof. Thomas Berg and Prof. Raymond Chung discuss the highlights and new advances ...

S3-E53 - AASLD 2022 Liver Meeting Live Coverage: Part 1

S3-E53 - AASLD 2022 Liver Meeting Live Coverage: Part 1

In an insight-laden conversation recorded on site from Washington DC, Scott Friedman, Jörn Schattenberg, Rachel Zayas and ...

2013 AASLD Distinguished Achievement Award

2013 AASLD Distinguished Achievement Award

This video was taken at The Liver Meeting 2013. The recipient of this award was Roger Williams, C.B.E. MD, FRCP, FRCS, ...

EASL Studio S9E3 Promo: Hepatitis C

EASL Studio S9E3 Promo: Hepatitis C

Hepatitis C, Re-infection or Failure of

2025 AASLD Updates from Northwestern Medicine Experts

2025 AASLD Updates from Northwestern Medicine Experts

In this episode of Better Edge, Sean W. P. Koppe, MD, moderates a panel of Northwestern Medicine hepatologists as they discuss ...

APASL Hepatology Webinar

APASL Hepatology Webinar

Yes we will move to the final

APASL Hepatology Webinar Episode-3 Session-1

APASL Hepatology Webinar Episode-3 Session-1

Date: Saturday August 8, 2020 Moderators: Dr. Grace Wong (Hong Kong), Dr. Fu-Sheng Wang (Beijing) Topics & Speakers Topic ...

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Debrief from EASL-AASLD Conference: Alcohol related Liver Disease

Alcohol related liver disease remains the most important cause of liver disease morbidity and mortality in Europe and North ...